B7-H3/CD276 (C-Term) Rabbit Monoclonal Antibody (Clone RM335)

B7-H3, also known as CD276, is a type I transmembrane glycoprotein and member of the B7-CD28 immune checkpoint protein family with roles in the T cell-mediated immune response.^1,2 It is encoded by CD276 in humans and is composed of an N-terminal signal peptide, an extracellular domain containing two identical pairs of immunoglobulin (Ig) constant (IgC) and variable (IgV) domains, a transmembrane region, and an intracellular tail. CD276 is ubiquitously expressed, however, protein expression is post-transcriptionally regulated.² B7-H3 protein is constitutively expressed on non-immune fibroblasts, endothelial cells, and osteoblasts, and can be induced in immune cells such as dendritic cells, macrophages, natural killer (NK) cells, and T cells. It inhibits NK cell-mediated lysis, as well as induces co-inhibition of T cells, increases activation of tumor-specific cytotoxic T cells, and decreases proliferation of CD4⁺ and CD8⁺ T cells through modulation of nuclear factor of activated T cells (NFAT), NF-κB, and AP-1. Serum levels of B7-H3 are increased in patients with sepsis, as are intestinal levels in patients with graft versus host disease. High tumor levels of B7-H3 protein are associated with increased tumor size, poorly differentiated tumors, lymph invasion, and shorter overall survival in patients with lung and breast cancers.³ Cayman's B7-H3/CD276 (C-Term) Rabbit Monoclonal Antibody (Clone RM335) can be used for immunohistochemistry (IHC) and Western blot (WB) applications.

WARNING This product is not for human or veterinary use.

1. Li, G., Quan, Y., Che, F., et al. B7-H3 in tumors: friend or foe for tumor immunity? Cancer Chemother. Pharmacol. 81(2), 245-253 (2018).

2. Janakiram, M., Shah, U.A., Liu, W., et al. The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3. Immunol. Rev. 276(1), 26-39 (2017).

3. He, L., and Li, Z. B7-H3 and its role in bone cancers. Pathol. Res. Pract. 215(6), 152420 (2019).